{"disease":{"id":"dalpiciclib","name":"dalpiciclib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07581834","title":"Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}